Related Experiment Video
Updated: Jul 19, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
[Diagnosis and clinical therapy for Parkinson's disease]
S Wenzel1, B Mollenhauer, C Trenkwalder
1Paracelsus-Elena-Klinik, Klinikstrasse 16, 34128 Kassel, Germany. dr.sascha.wenzel@pk-mx.de
Abstract:
For decades, awareness of Parkinson's disease mainly focused on the presence and treatment of motor symptoms. More and more other symptoms of this disease not related to the motor system now receive increased attention, including cognitive decline. Dementia in Parkinson's disease occurs more often than initially was thought. After an average of 8 years, about 40% of these patients suffer from cognitive decline. The difficulties and related problems affect prognosis more than do the motor symptoms. There is a need for standardized diagnostic and specific therapeutic intervention, but appropriate studies are still lacking.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Alzheimer's Disease: Treatment
Alterations in Muscle Tone lll
